HOME >> MEDICINE >> NEWS
Preventing another Vioxx

ANN ARBOR, Mich.-- The arthritis drug Vioxx eased the pain of millions of patients -- but it also greatly increased the risk of heart attack and stroke among some of them. And that extra risk only came to light through after-the-fact analysis of data from Vioxx research studies.

Failure to identify such medical safety problems may often go unnoticed but could frequently be prevented if medical researchers changed the way they evaluate new medicines, medical devices and other treatments, according to a new paper in the journal Health Affairs. Such changes may have to be mandated, say the authors from the Veterans Affairs Ann Arbor Healthcare System and the University of Michigan Health System.

The paper's authors say there are fundamental flaws in the way researchers usually analyze and report the results of medical studies, especially randomized clinical trials that are seen as the "gold standard" method for studying the effectiveness and safety of new treatments. Those flaws make it more likely that they'll miss signs of extra harm -- or extra benefit -- to subgroups of patients who have certain characteristics.

Only by analyzing results using a statistical method that considers several factors at once -- for instance, overall heart attack risk, rather than just individual risk factors such as age -- will researchers truly be able to see how the risks and benefits of a treatment vary from patient to patient, the study suggests.

This kind of analysis, called multivariable or risk-stratified analysis, would require more statistical know-how. But it could save lives and money, and allow patients to weigh a treatment's true risks and benefits to their health before starting treatment.

"Most studies currently emphasize the average risk and average benefit found in the study, but the average trial participant might get much less benefit than average, or even be harmed," says lead author Rodney Hayward, M.D. "If 9 people are in a r
'"/>

Contact: Kara Gavin
kegavin@umich.edu
734-764-2220
University of Michigan Health System
10-Nov-2005


Page: 1 2 3 4 5

Related medicine news :

1. IOM Advisory: Preventing Medication Errors News Conference on July 20
2. Preventing spinal cord injury during aortic surgery
3. Preventing toxic side effects of inflammatory disease therapy
4. An ISN Bellagio Summit - Preventing vascular diseases around the world
5. Preventing pneumonia in children helps prevent pneumonia in older adults
6. Preventing chronic diseases - need for concerted action
7. Preventing communication errors in telephone medicine
8. Medical management of another condition may not lead to early cancer diagnosis
9. Call for countries tackling HIV epidemics to learn from one another on 25th anniversary
10. UCLA paper examines how one disease may prevent another
11. Mental stress may be another culprit in raising cholesterol levels in healthy adults

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/13/2019)... ... June 13, 2019 , ... The Stevie® Awards, organizer ... deadline in the 2019 competition is extended to July 18. The original final ... awards program, The IBAs attract nominations from organizations in more than 70 nations ...
(Date:6/13/2019)... ... June 13, 2019 , ... GlycoMark, Inc. announced a new ... Diabetes Association (ADA) Scientific Sessions 2019 involving the GlycoMark test being used for ... SGLT-2 inhibitors are used to lower glucose levels in patients with diabetes by ...
(Date:6/12/2019)... ... June 12, 2019 , ... Learn how to succeed in ... innovative branding and network with others in this growing field. , What are ... manufacturers and others who are part of the rapidly evolving cannabis industry will ...
(Date:6/12/2019)... , ... June 12, 2019 , ... ... the newest addition to the family of Best Sanitizers’ HACCP Footwear Sanitizing Unit ... processing facilities, nutraceutical plants, pharmaceutical plants, clinical research labs, and clean rooms by ...
(Date:6/11/2019)... ... June 11, 2019 , ... The FSH Society today announced ... government regulators, biopharma companies, and academic thought leaders to discuss the current state ... is the world’s largest research-focused patient advocacy organization for FSHD, a hereditary muscle-damaging ...
Breaking Medicine News(10 mins):
(Date:6/11/2019)... ... June 11, 2019 , ... The National ... NCCN Chemotherapy Order Templates ( NCCN Templates ®) into the CureMD Oncology EHR ... the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®). , “The collaboration with ...
(Date:6/6/2019)... ... ... MEDICC (Medical Education Cooperation with Cuba) has deplored the Trump administration’s decision ... more assault on the freedom of Americans, Cuban-Americans and the health and livelihoods of ... Directors. , MEDICC has long stood for open dialogue and cooperation with Cuban ...
(Date:6/6/2019)... ... 05, 2019 , ... Cobb-Vantress, Inc. / Siloam Springs, Arkansas, ... avian influenza virus from replicating in lab-grown chicken cells, suggesting that it may ... The study was funded by Biotechnology and Biological Sciences Research Council with additional ...
Breaking Medicine Technology:
Cached News: